BARCELONA, Spain--(BUSINESS WIRE)--OMNIVISION, a leading global developer of semiconductor solutions, including advanced digital imaging, analog and touch & display technology, and Philips, a global technology company focused on improving people’s health and well-being through meaningful innovation in healthcare and consumer lifestyle, today announced they will jointly demonstrate a prototype of the world’s first in-cabin connected well-being monitoring solution at AutoSens Europe, taking place October 8-10, 2024, at Palau de Congressos, Barcelona, Spain..

西班牙巴塞罗那——（商业新闻短讯）——全球领先的半导体解决方案开发商OMNIVISION（包括先进的数字成像、模拟和触摸显示技术）和全球科技公司飞利浦（Philips）今天宣布，他们将于2024年10月8日至10日在西班牙巴塞罗那帕劳国会大厦（Palau de Congressos）在欧洲汽车展（AutoSens Europe）联合展示世界上第一款车内连接幸福感监测解决方案的原型。。

The in-cabin health and well-being system monitors vital signs such as pulse and breathing ratei. The data may enable customization of comfort settings while driving, such as intelligently adapting media, climate, lighting, seating, engine modes, scent and more. It will also help enable timed delivery of vehicle notifications or make adaptive route and break suggestionsii..

机舱内健康和幸福系统监测脉搏和呼吸频率等生命体征。。它还将有助于定时发送车辆通知，或提出自适应路线和休息建议II。。

“Automotive OEMs are continuously looking to add value and differentiate their brands by adding novel features that increase the comfort level in cars,” said Ritesh Agarwal, senior automotive marketing manager, OMNIVISION. “As a leading supplier of image sensors for the automotive market, we have partnered with Philips, a renowned health and well-being technology software provider, to develop vital signs monitoring solution particularly tailored to the automotive industry, which has the potential to be connected to the comfort and safety settings of the car.

OMNIVISION高级汽车营销经理Ritesh Agarwal表示：“汽车原始设备制造商一直在寻求通过增加新颖功能来提高汽车舒适度，从而增加价值并使其品牌与众不同。”。“作为汽车市场图像传感器的领先供应商，我们与飞利浦（Philips）合作，飞利浦是一家著名的健康和福利技术软件提供商，专门为汽车行业开发生命体征监测解决方案，该解决方案有可能与汽车的舒适性和安全性设置相关联。

This in-cabin solution will bring added value to automotive consumers and shorten time to market for tier-one automotive OEMs.”.

这种车内解决方案将为汽车消费者带来附加价值，并缩短一级汽车OEM的上市时间。”。

“By collaborating with OMNIVISION, we have demonstrated that camera sensors already available in the automotive industry are capable of accurately measuring vital signs such as pulse rate and breathing rate,” said Laurens Pronk, business development manager EMEA, Philips. “Philips has over 20 years of experience in developing and clinically validating patented vital signs monitoring algorithms for various sensor technologies.

飞利浦EMEA业务开发经理劳伦斯·普龙克（LaurensPronk）表示：“通过与OMNIVISION的合作，我们证明了汽车行业已有的摄像头传感器能够准确测量脉搏率和呼吸频率等生命体征。”。“飞利浦在为各种传感器技术开发和临床验证专利生命体征监测算法方面拥有20多年的经验。

We have partnered with OMNIVISION, an industry leader in in-cabin automotive image sensors, to leverage our joint capabilities and demonstrate this state-of-the-art technology during AutoSens Europe.”.

我们已经与OMNIVISION合作，OMNIVISION是车内汽车图像传感器的行业领导者，以利用我们的联合能力，并在欧洲汽车展上展示这种最先进的技术。”。

The demonstrated prototype combines Philips’ vital signs camera for automotive software with OMNIVISION’s state-of-the-art OX05B1S CMOS image sensor, a 5-megapixel (MP) RGB-IR backside illuminated (BSI) global shutter sensor for in-cabin monitoring systems. The image sensor features Nyxel® technology, which uses novel silicon semiconductor architectures and processes to achieve the industry leading quantum efficiency at the 940nm near-infrared (NIR) wavelength.

演示的原型将飞利浦汽车软件生命体征摄像头与OMNIVISION最先进的OX05B1S CMOS图像传感器相结合，该传感器是一种500万像素（MP）RGB-IR背面照明（BSI）全局快门传感器，用于车内监控系统。图像传感器采用Nyxel®技术，该技术使用新型硅半导体结构和工艺，在940nm近红外（NIR）波长下实现业界领先的量子效率。

This enables the OX05B1S to detect and recognize objects that other image sensors would miss under extremely low lighting conditions, providing higher performance in-cabin camera capabilities. An advanced artificial intelligence (AI)-enabled OAX4600 image signal processor seamlessly processes the data from the image sensor for the med-tech system..

这使得OX05B1S能够检测和识别其他图像传感器在极低光线条件下会错过的物体，从而提供更高性能的座舱摄像机功能。支持高级人工智能（AI）的OAX4600图像信号处理器可无缝处理med tech系统图像传感器的数据。。

For more information, contact an OMNIVISION sales representative at www.ovt.com/contact-sales or visit OMNIVISION at AutoSens Europe, Booth 300.

有关更多信息，请通过www.ovt.com/contact-sales联系OMNIVISION销售代表，或访问AutoSens Europe 300号展位的OMNIVISION。

About OMNIVISION

关于OMNIVISION

OMNIVISION is a global fabless semiconductor organization that develops advanced digital imaging, analog and touch & display solutions for multiple applications and industries, including mobile phones, security and surveillance, automotive, computing, medical, machine vision and emerging applications.

OMNIVISION是一家全球无晶圆厂半导体组织，为多种应用和行业开发先进的数字成像、模拟和触摸显示解决方案，包括手机、安全和监控、汽车、计算、医疗、机器视觉和新兴应用。

Its award-winning innovative technologies enable a smoother human/machine interface in many of today’s commercial devices. Find out more at www.ovt.com..

它屡获殊荣的创新技术使当今许多商业设备的人机界面更加平滑。有关更多信息，请访问www.ovt.com。。

About Royal Philips

关于皇家飞利浦

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology, deep clinical, and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home..

皇家飞利浦是一家领先的科技公司，专注于通过有意义的创新来改善人们的健康和福祉。飞利浦以患者和人为中心的创新利用先进的技术、深入的临床和消费者见解，为消费者提供个人健康解决方案，为医疗保健提供者及其医院和家中的患者提供专业健康解决方案。。

News about Philips can be found at www.philips.com/newscenter.

有关飞利浦的新闻，请访问www.Philips.com/newscenter。

OMNIVISION®, Nyxel® and the OMNIVISION logo are trademarks or registered trademarks of OMNIVISION. All other trademarks are the property of their respective owners.

OMNIVISION®、Nyxel®和OMNIVISION徽标是OMNIVISION的商标或注册商标。所有其他商标均为其各自所有者的财产。

_______________

_______________

i For technology demonstration purposes only. Prior to commercial distribution appropriate regulatory authorizations for the intended market will be obtained by the legal manufacturer of the end-product.

i仅用于技术演示目的。在商业分销之前，最终产品的合法制造商将获得预期市场的适当监管授权。

ii This product is not intended to diagnose, treat, cure, or prevent any disease and these statements have not been evaluated by any global regulatory agency.

ii本产品不用于诊断、治疗、治愈或预防任何疾病，并且这些声明未经任何全球监管机构评估。